by Lisa Willemse | Jan 31, 2014
> By now, most readers will be familiar with this week’s announcement of a remarkable new discovery that mouse cells were made pluripotent using a relatively simple and quick acid bath technique. For those who aren’t, there’s reams of coverage,...
by Paul Krzyzanowski | Nov 21, 2012
While the 2012 US election was in full swing, I reminded readers that despite the dominance of the world’s economic problems in this cycle, stem cell research was a political issue that hadn’t completely gone away.[pullquote]Ironically, if – and this is a...
by Ubaka Ogbogu | May 18, 2012
The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled...
by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by David Kent | Feb 29, 2012
Last week I attended a breakfast at Eversheds, a law firm in Cambridge entitled Stem cell patenting, Brüstle v Greenpeace: business breaker or business as usual? which focused on the practical implications of the recent decision from the Court of Justice of the...
Comments